19.1 C
New York
Saturday, June 3, 2023

Mersana Therapeutics Inc. (MRSN): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Mersana Therapeutics Inc. (MRSN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.13, or 1.61%, to $8.21. The Mersana Therapeutics Inc. has recorded 38,579 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $8.08 and fluctuated between $8.39 as its day high and $7.85 as its day low. The current market capitalization of Mersana Therapeutics Inc. is $864.08M. A total of 5.09 million shares were traded on the day, compared to an average of 1.75M shares.

Insider Activity

Insider trades can also provide insight into a stock’s future direction. During the recent three months, MRSN has seen 2 BUY and 0 SELL insider trades, representing the acquisition of 8,241 and the disposition of 0 shares. Over the last 12 months, there were 33 BUYs and 10 SELLs from insiders. Insiders purchased 1,348,215 shares during that period but sold 283,384.

In the most recent transaction, Carvajal Alejandra sold 3,944 shares of MRSN for 3.89 per share on Apr 27. After the transaction, the SVP, Chief Legal Officer now owns 20,326 company shares. In a previous transaction on Jan 17, Protopapas Anna sold 17,346 shares at 5.74 per share. MRSN shares that President & CEO owns now total 48,733.

Among the insiders who sold shares, Lowinger Timothy B disposed of 6,233 shares on Jan 17 at a per-share price of $5.74. This resulted in the SVP, Chief Sci.&Tech. Off. holding 180,363 shares of MRSN after the transaction. In another insider transaction, DeSchuytner Brian sold 5,131 shares at $5.74 per share on Jan 17. Company shares held by the SVP, Chief Financial Officer now total 32,781.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for MRSN in the last 3 months, the mean price target is $14.71 with high estimates of $20.00 and low estimates of $11.00. In terms of 52-week highs and lows, MRSN has a high of $8.34 and a low of $2.68.

As of this writing, MRSN has an earnings estimate of -$0.5 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.44 per share and a lower estimate of -$0.56. The company reported an EPS of -$0.44 in the last quarter, which was 12.00% higher than expectations of -$0.5.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MRSN’s latest balance sheet shows that the firm has $177.95M in Cash & Short Term Investments as of fiscal 2021. There were $38.18M in debt and $47.52M in liabilities at the time. Its Book Value Per Share was $0.91, while its Total Shareholder’s Equity was $121.74M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRSN is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles